Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Cardiotoxicity × Clear all

Phase

Phase 2 5 Phase 1 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 48 Neoplasms 36 Carcinoma, Non-Small-Cell Lung 25 Prostatic Neoplasms 24 Polycystic Ovary Syndrome 16 Pain 15 Keratosis, Actinic 14 Leukemia 12 Colorectal Neoplasms 11 Uterine Cervical Neoplasms 10 Pancreatic Neoplasms 10 Lung Neoplasms 10 Leiomyoma 10 Carcinoma, Hepatocellular 10 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Lymphoma, Follicular 9 Carcinoma, Renal Cell 9 Brain Neoplasms 9 Neuroendocrine Tumors 8 Arthritis, Rheumatoid 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Melanoma 7 Kidney Neoplasms 7 Head and Neck Neoplasms 7 Colonic Neoplasms 7 Cancer Pain 7 Multiple Myeloma 6 Lymphoma 6 Liver Neoplasms 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02696707 2025-12-18

OTT 15-05

Ottawa Hospital Research Institute

Phase 4 Completed

200 enrolled 8 charts

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡